CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen 41st Annual Health Care Conference.

Read more from the original source:
GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *